Avaliação de diferentes crioprotetores intra e extracelulares na criopreservação de sêmen de touros / Evaluation of different intra and extracellular cryoprotectants on bull semen cryopreservation

Em um delineamento experimental usando o fatorial 3x2, três crioprotetores internos, glicerol (GLI), etilenoglicol (EG) e dimetilformamida (DMF), e dois externos, gema de ovo (GEMA) e lipoproteína de baixa densidade (LDL), avaliaram-se a motilidade ao descongelamento de GLI-GEMA 53,9±1,96, sendo superior aos demais tratamentos (P<0,05). Na avaliação de morfologia ao descongelamento, não houve diferença (P>0,05) entre os tratamentos EG-GEMA 68,3±1,58, EG-LDL 72,2±2,39 e DMF-GEMA 68,7±1,67 que foram mais altos que os demais (P<0,05). A avaliação de integridade de membrana por fluorescência ao descongelamento GLI-GEMA 34,2±2,28 e EG-GEMA 30,9±1,32 não diferiram entre si (P>0,05), mas foram mais elevados que os demais (P<0,05), enquanto que a HOST dos tratamentos DMF-GEMA 13,6±1,30 e DMF-LDL 9,8±0,78 diferirem entre si (P<0,05) e foram mais baixas que as demais (P<0,05). O uso de etilenoglicol associado à gema de ovo pode ser uma alternativa ao uso de glicerol nos protocolos de congelamento de sêmen de touros.

The experiment was designed as 3 x 2 factorial design, with three internal cryoprotectants, glycerol (GLY), etileneglycol (EG) and dymethilformamide (DMF) and two external, egg yolk (YOLK) and density low lipoproteina (LDL). The motility at thawing for GLY-YOLK (53.9±1.96) was higher than other treatments (P<0.05). The percentage of cells with normal morphology at thawing was not different between EG-YOLK (68.3±1.58), EG-LDL (72.2±2.39) and DMF-YOLK (68.7±1.67), but they were higher than the others (P<0.05). The evaluation of membrane integrity through fluorescent probes at thawing indicate that GLY-YOLK (34.2±2.28) and EG-YOLK (30.9±1.32) were not different (P>0.05), but were higher than the others (P<0.05). The evaluation of membrane integrity through hypoosmotic swelling test (HOST) indicate that DMF-YOLK (13.6±1.30) and DMF-LDL (9.8±0.78) were different (P<0.05) and lower than the others (P<0.05). The use of ethylene glycol associated to egg yolk can be a viable alternative to the use of glycerol in bull semen freezing protocols.

Oocistos deCryptosporidium parvum em fezes de bezerro infectado experimentalmente / Cryptosporidium parvum oocysts in the feces of experimentally infected calf

A dose of 5.0x106 Cryptosporidium parvum oocysts was inoculated in a newborn calf. After the inoculation, the feces were daily collected and the presence of oocysts was examined on slides using 0.17% green malachite dye. The total yield reached 1.5x1010 oocysts, with a peak production on the 7th day, confirming the infectious process and the role of calf infection in the potential risk for environmental contamination.

Transient high-level expression of ß-galactosidase after transfection of fibroblasts from GM1 gangliosidosis patients with plasmid DNA

GM1 gangliosidosis is an autosomal recessive disorder caused by the deficiency of lysosomal acid hydrolase ß-galactosidase (ß-Gal). It is one of the most frequent lysosomal storage disorders in Brazil, with an estimated frequency of 1:17,000. The enzyme is secreted and can be captured by deficient cells and targeted to the lysosomes. There is no effective treatment for GM1 gangliosidosis. To determine the efficiency of an expression vector for correcting the genetic defect of GM1 gangliosidosis, we tested transfer of the ß-Gal gene (Glb1) to fibroblasts in culture using liposomes. ß-Gal cDNA was cloned into the expression vectors pSCTOP and pREP9. Transfection was performed using 4 µL lipofectamine 2000 and 1.5-2.0 µg DNA. Cells (2 x 10(5)/well) were harvested 24 h, 48 h, and 7 days after transfection. Enzyme specific activity was measured in cell lysate and supernatant by fluorometric assay. Twenty-four hours after transfection, treated cells showed a higher enzyme specific activity (pREP9-ß-Gal: 621.5 ± 323.0, pSCTOP-ß-Gal: 714.5 ± 349.5, pREP9-ß-Gal + pSCTOP-ß-Gal: 1859.0 ± 182.4, and pREP9-ß-Gal + pTRACER: 979.5 ± 254.9 nmol·h-1·mg-1 protein) compared to untreated cells (18.0 ± 3.1 for cell and 32.2 ± 22.2 nmol·h-1·mg-1 protein for supernatant). However, cells maintained in culture for 7 days showed values similar to those of untreated patients. In the present study, we were able to transfect primary patients' skin fibroblasts in culture using a non-viral vector which overexpresses the ß-Gal gene for 24 h. This is the first attempt to correct fibroblasts from patients with GM1 gangliosidosis by gene therapy using a non-viral vector.